Literature DB >> 23106271

Targeting antibiotic resistance mechanisms in Mycobacterium tuberculosis: recharging the old magic bullets.

Liem Nguyen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23106271      PMCID： PMC3970175          DOI： 10.1586/eri.12.85

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN： 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  18 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  From the analyst's couch. Trends in development cycles.

Authors:  Barbara M Bolten; Tracy DeGregorio
Journal:  Nat Rev Drug Discov       Date:  2002-05       Impact factor: 84.694

3.  Rifapentine for the treatment of tuberculosis: is it all it can be?

Authors:  Fred M Gordin
Journal:  Am J Respir Crit Care Med       Date:  2004-06-01       Impact factor: 21.405

4.  MDR, XDR, TDR tuberculosis: ominous progression.

Authors:  Zarir F Udwadia
Journal:  Thorax       Date:  2012-04       Impact factor: 9.139

Review 5.  The magic bullets and tuberculosis drug targets.

Authors:  Ying Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

6.  Sampling the antibiotic resistome.

Authors:  Vanessa M D'Costa; Katherine M McGrann; Donald W Hughes; Gerard D Wright
Journal:  Science       Date:  2006-01-20       Impact factor: 47.728

Review 7.  From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis.

Authors:  Susan E Dorman; Richard E Chaisson
Journal:  Nat Med       Date:  2007-03       Impact factor: 53.440

Review 8.  Current prospects for the fluoroquinolones as first-line tuberculosis therapy.

Authors:  Howard Takiff; Elba Guerrero
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

9.  Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.

Authors:  G Senol; A Erbaycu; A Ozsöz
Journal:  J Chemother       Date:  2005-08       Impact factor: 1.714

10.  A synthetic mammalian gene circuit reveals antituberculosis compounds.

Authors:  Wilfried Weber; Ronald Schoenmakers; Bettina Keller; Marc Gitzinger; Thomas Grau; Marie Daoud-El Baba; Peter Sander; Martin Fussenegger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205
View more
  7 in total

Review 1.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

2.  The Pup-Proteasome System Protects Mycobacteria from Antimicrobial Antifolates.

Authors:  Marissa B Guzzo; Qing Li; Hoang V Nguyen; W Henry Boom; Liem Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

4.  Comparison of the membrane proteome of virulent Mycobacterium tuberculosis and the attenuated Mycobacterium bovis BCG vaccine strain by label-free quantitative proteomics.

Authors:  Harsha P Gunawardena; Meghan E Feltcher; John A Wrobel; Sheng Gu; Miriam Braunstein; Xian Chen
Journal:  J Proteome Res       Date:  2013-10-28       Impact factor: 4.466

Review 5.  Molecular biology of drug resistance in Mycobacterium tuberculosis.

Authors:  Tasha Smith; Kerstin A Wolff; Liem Nguyen
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

6.  Methylfolate Trap Promotes Bacterial Thymineless Death by Sulfa Drugs.

Authors:  Marissa B Guzzo; Hoa T Nguyen; Thanh H Pham; Monika Wyszczelska-Rokiel; Hieronim Jakubowski; Kerstin A Wolff; Sam Ogwang; Joseph L Timpona; Soumya Gogula; Michael R Jacobs; Markus Ruetz; Bernhard Kräutler; Donald W Jacobsen; Guo-Fang Zhang; Liem Nguyen
Journal:  PLoS Pathog       Date:  2016-10-19       Impact factor: 6.823

7.  Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis.

Authors:  Md Imtiazul Islam; Hoonhee Seo; Sukyung Kim; Venkata S Sadu; Kee-In Lee; Ho-Yeon Song
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.